Vivos Therapeutics, Inc. ( (VVOS) ) has released its Q2 earnings. Here is a breakdown of the information Vivos Therapeutics, Inc. presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vivos Therapeutics, Inc. is a medical technology company specializing in proprietary oral appliances and therapeutic treatments for sleep disorders, particularly obstructive sleep apnea (OSA). The company operates in the healthcare sector and is known for its innovative, non-surgical solutions for maxillofacial abnormalities linked to breathing and sleep issues.
In its latest earnings report for the quarter ending June 30, 2025, Vivos Therapeutics highlighted a strategic shift in its business model, focusing on acquisitions and alliances with sleep centers to drive revenue. This pivot aims to reduce reliance on dentist-driven sales and capitalize on direct patient interactions through sleep disorder centers.
Financially, the company reported a decrease in total revenue to $3.82 million for the quarter, down from $4.05 million the previous year. The net loss widened to $5.01 million compared to a loss of $1.93 million in the same quarter last year. This increase in losses is attributed to higher operating expenses, primarily due to the acquisition of The Sleep Center of Nevada and the associated costs.
Despite the current financial challenges, Vivos Therapeutics is optimistic about its new business strategy. The acquisition of The Sleep Center of Nevada is expected to enhance its market presence and provide new revenue streams. The company is actively exploring further acquisitions and partnerships to expand its reach in the sleep disorder treatment market.
Looking ahead, Vivos Therapeutics’ management remains focused on integrating its recent acquisition and refining its sales, marketing, and distribution model. The company aims to leverage its innovative products and strategic alliances to achieve sustainable growth and improve financial performance in the coming quarters.